Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a
leading buyer of life insurance policies and vertically integrated
alternative asset manager specializing in specialty insurance
products, today reported results for the quarter ended September
30, 2023.
“Our strong third quarter results continue to
validate Abacus' differentiated business model and further
contributes to our solid track record of sustained growth,” said
Jay Jackson, Chief Executive Officer of Abacus. “We achieved
additional milestones following the end of the third quarter,
successfully completing our first public bond offering and
refinancing prior debt with the proceeds, improving our cost of
capital by approximately 275 basis points while extending our
maturity wall.”
“We also recently announced the launch of our
new wealth division, ABL Wealth, to offer clients custom
lifespan-based financial solutions in partnership with Dynasty
Financial Partners, one of the country’s leading wealth management
platforms for independent wealth management firms. As we close out
2023, we believe our proven business model positions us to continue
executing on our multiple strategic growth initiatives, generating
sustained profitability and ultimately creating long-term value for
our shareholders,” concluded Jackson.
Third Quarter 2023 Highlights (on a
Proforma Basis)
- Total
revenue for the third quarter of 2023 grew 20% to $21.1 million,
compared to $17.5 million in the prior-year period.
-
Originations capital deployment for the third quarter of 2023
increased 43% to $51 million, compared to $34 million in the
prior-year period; number of policy originations for the third
quarter of 2023 grew 61% to 181, compared to 112 in the prior-year
period.
- GAAP net
income attributable to shareholders for the third quarter of 2023
was $0.9 million, compared to $11.2 million in the prior-year
period.
- Adjusted
net income was $9.2 million, compared to $10.2 million in the
prior-year period.
- Adjusted
EBITDA for the third quarter of 2023 grew 26% to $10.8 million,
compared to $8.5 million in the prior-year period, which was
primarily attributable to strong revenue growth, partially offset
by higher operating expenses. Adjusted EBITDA margin (a non-GAAP
measure) for the third quarter of 2023 was 51.1%, compared to 48.7%
in the prior-year period.
-
Annualized return on invested capital (ROIC) (a non-GAAP measure
defined below) for the third quarter of 2023 was 2.8%; adjusted
ROIC of 29%.
-
Annualized Return on equity (ROE) (a non-GAAP measure defined
below) for the third quarter of 2023 was 2.2%; adjusted ROE of
22%.
- Total
operating expenses for the third quarter of 2023 were $12.9
million, compared to $1.4 million in the prior-year period. Higher
operating expenses were primarily driven by non-cash expense of
$4.6 million related to employee stock compensation and public
company expenses incurred in the third quarter of 2023 that were
not recorded in the prior-year period.
Third Quarter 2023 Results (on a
Proforma Basis)
- Active
management revenue for the third quarter of 2023 increased 70% to
$18.9 million, compared to $11.1 million in the prior-year period,
primarily due to increased policy acquisition and realized trade
revenue.
- Total revenue from portfolio
servicing segment for the third quarter of 2023 was $0.2 million,
compared to $0.4 million in the prior-year period.
- Total
Originations revenue for the third quarter of 2023 was $2.0
million, compared to $6.0 million in the prior-year period,
primarily due to fewer policies sold to third parties.
- GAAP net
income attributable to shareholders for the third quarter of 2023
of $0.9 million, compared to GAAP net income attributable to
shareholders of $11.2 million in the prior-year period, primarily
driven by a non-cash expense of $4.6 million related to employee
stock compensation and public company expenses incurred in the
third quarter of 2023 that were not recorded in the prior-year
period.
Liquidity and Capital
As of September 30, 2023, the Company had cash
and cash equivalents of $36.6 million, balance sheet policy assets
of $87.7 million and outstanding long-term debt of $118.8
million.
Webcast and Conference Call
A webcast and conference call to discuss the
Company’s results will be held today beginning at 9:00 a.m.
(Eastern Time). A live webcast of the conference call will be
available on Abacus Life’s investor relations website at
ir.abacuslife.com. The dial-in number for the conference call is
(877) 407-9716 (toll-free) or (201) 493-6779 (international).
Please dial the number 10 minutes prior to the scheduled start
time.
A webcast replay of the call will be available
at ir.abacuslife.com for one year following the call.
Non-GAAP Financial
Information
Adjusted Net Income, a non-GAAP measure, is
defined as net income (loss) attributable to Abacus adjusted for
non-controlling interest income, amortization, change in fair value
of warrants and non-cash stock-based compensation and the related
tax effect of those adjustments. Management believes that Adjusted
Net Income is an appropriate measure of operating performance
because it eliminates the impact of expenses that do not relate to
business performance. A reconciliation of Adjusted Net Income to
Net income attributable to Abacus, the most directly comparable
GAAP measure, appears below.
Adjusted EBITDA, a non-GAAP measure, is defined
as net income (loss) attributable to Abacus adjusted for
depreciation expense, amortization, interest expense, income tax
and other non-cash and non-recurring items that in our judgement
significantly impact the period-over-period assessment of
performance and operating results that do not directly relate to
business performance within Abacus’ control.]. A reconciliation of
Adjusted EBITDA to Net income attributable to Abacus Life, the most
directly comparable GAAP measure, appears below.
Adjusted EBITDA margin, a non-GAAP measure, is
defined as Adjusted EBITDA divided by Total revenues. A
reconciliation of Adjusted EBITDA margin to Net income margin, the
most directly comparable GAAP measure, appears below.
Annualized return on invested capital (ROIC), a
non-GAAP measure, is defined as Adjusted net income for the quarter
divided by the result of Total Assets less Intangible assets, net,
Goodwill and Current Liabilities multiplied by four. ROIC is not a
measure of financial performance under GAAP. We believe ROIC should
be considered in addition to, not as a substitute for, operating
income or loss, net income or loss, cash flows provided by or used
in operating, investing and financing activities or other income
statement or cash flow statement line items reported in accordance
with GAAP.
Annualized return on equity (ROE), a non-GAAP
measure, is defined as [Adjusted net income divided by total
shareholder equity multiplied by four. ROE is not a measure of
financial performance under GAAP. We believe ROE should be
considered in addition to, not as a substitute for, operating
income or loss, net income or loss, cash flows provided by or used
in operating, investing and financing activities or other income
statement or cash flow statement line items reported in accordance
with GAAP. The below table presents our calculation of ROE.
Forward-Looking Statements
All statements in this press release (and oral
statements made regarding the subjects of this press release) other
than historical facts are forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934, as
amended. These forward-looking statements rely on a number of
assumptions concerning future events and are subject to a number of
uncertainties and factors that could cause actual results to differ
materially from such statements, many of which are outside the
control of Abacus. Forward-looking information includes but is not
limited to statements regarding: Abacus’s financial and operational
outlook; Abacus’s operational and financial strategies, including
planned growth initiatives and the benefits thereof, Abacus’s
ability to successfully effect those strategies, and the expected
results therefrom. These forward-looking statements generally are
identified by the words “believe,” “project,” “estimate,” “expect,”
”intend,” “anticipate,” “goals,” “prospects,” “will,” “would,”
“will continue,” “will likely result,” and similar expressions
(including the negative versions of such words or expressions).
While Abacus believes that the assumptions
concerning future events are reasonable, it cautions that there are
inherent difficulties in predicting certain important factors that
could impact the future performance or results of its business. The
factors that could cause results to differ materially from those
indicated by such forward-looking statements include, but are not
limited to: the fact that Abacus’s loss reserves are bases on
estimates and may be inadequate to cover its actual losses; the
failure to properly price Abacus’s insurance policies; the
geographic concentration of Abacus’s business; the cyclical nature
of Abacus’s industry; the impact of regulation on Abacus’s
business; the effects of competition on Abacus’s business; the
failure of Abacus’s relationships with independent agencies; the
failure to meet Abacus’s investment objectives; the inability to
raise capital on favorable terms or at all; the effects of acts of
terrorism; and the effectiveness of Abacus’s control environment,
including the identification of control deficiencies.
These forward-looking statements are also
affected by the risk factors, forward-looking statements and
challenges and uncertainties set forth in documents filed by Abacus
with the U.S. Securities and Exchange Commission from time to
time, including the Annual Report on Form 10-K and Quarterly
Reports on Form 10-Q and subsequent periodic reports. These
filings identify and address other important risks and
uncertainties that could cause actual events and results to differ
materially from those contained in the forward-looking statements.
Abacus cautions you not to place undue reliance on the
forward-looking statements contained in this press release.
Forward-looking statements speak only as of the date they are made.
Readers are cautioned not to put undue reliance on forward-looking
statements, and Abacus assumes no obligation and, except as
required by law, does not intend to update or revise these
forward-looking statements, whether as a result of new information,
future events, or otherwise. Abacus does not give any assurance
that it will achieve its expectations.
About Abacus
Abacus is a leading vertically integrated
alternative asset manager and market maker, specializing in
longevity and actuarial technology. The company is democratizing
the life insurance space through three groundbreaking new channels:
ABL Tech, ABL Wealth, and ABL Longevity Funds. Since 2004, Abacus
has purchased life insurance policies from consumers seeking
liquidity and has actively managed those policies over time (via
trading, holding, and/or servicing). With over $4.6BN in face value
of policies purchased, we have helped thousands of clients maximize
the value of life insurance. Abacus Life is the only public life
settlement company, trading on the Nasdaq Exchange under the ticker
symbol ABL.
Over the past 19 years, the company has built an
institutionalized origination and portfolio management process that
is supported by a 95+ person team, long-term relationships with 78
institutional partners and 30,000 financial advisors, and the
ability to operate in 49 states. The Company complies with HIPAA
and privacy laws to maintain and protect confidentiality of
financial, health, and medical information. Abacus is also proud to
be a BBB Accredited Business with an A+ rating.
www.Abacuslife.com
Contact:Abacus Life Investor
Relationsinvestors@abacuslife.com Abacus Life Public
Relationspress@abacuslife.com
ABACUS LIFE, INC. Condensed Consolidated Balance
Sheets
|
September
30, |
|
December
31, |
2023 |
2022 |
(unaudited) |
|
ASSETS |
|
|
|
CURRENT
ASSETS: |
|
|
|
Cash and cash equivalents |
$ |
36,649,190 |
|
|
$ |
30,052,823 |
Accounts receivable |
|
960,720 |
|
|
|
10,448 |
Accounts receivable, related party |
|
174,875 |
|
|
|
198,364 |
Due from affiliates |
|
772,545 |
|
|
|
2,904,646 |
Prepaid expenses and other current assets |
|
961,427 |
|
|
|
116,646 |
Total current assets |
|
39,518,757 |
|
|
|
33,282,927 |
Property and equipment, net |
|
261,882 |
|
|
|
18,617 |
Intangible assets, net |
|
31,217,917 |
|
|
|
— |
Goodwill |
|
140,287,000 |
|
|
|
— |
Operating right-of-use assets |
|
171,295 |
|
|
|
77,011 |
Life settlement policies, at cost |
|
4,116,499 |
|
|
|
8,716,111 |
Life settlement policies, at fair value |
|
83,585,374 |
|
|
|
13,809,352 |
Available-for-sale securities, at fair value |
|
1,000,000 |
|
|
|
1,000,000 |
Other investments, at cost |
|
1,650,000 |
|
|
|
1,300,000 |
Other assets |
|
998,469 |
|
|
|
— |
Equity securities, at fair value |
|
1,494,744 |
|
|
|
890,829 |
TOTAL
ASSETS |
$ |
304,301,937 |
|
|
$ |
59,094,847 |
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY
(DEFICIT) |
|
|
|
CURRENT
LIABILITIES: |
|
|
|
Accrued expenses |
$ |
636,788 |
|
|
$ |
— |
Accounts payable |
|
2,000 |
|
|
|
40,014 |
Operating lease liability, current |
|
173,799 |
|
|
|
48,127 |
Due to affiliates |
|
5,236 |
|
|
|
263,785 |
Due to owners |
|
1,159,712 |
|
|
|
— |
Contract liabilities - deposits on pending settlements |
|
348,836 |
|
|
|
— |
Accrued transaction costs |
|
— |
|
|
|
908,256 |
Other current liabilities |
|
3,050,731 |
|
|
|
42,227 |
Income taxes payable |
|
80,573 |
|
|
|
— |
Total current liabilities |
|
5,457,675 |
|
|
|
1,302,409 |
|
|
|
|
Long-term debt- Related party |
|
36,535,778 |
|
|
|
— |
Long-term
debt |
|
82,278,050 |
|
|
|
28,249,653 |
Operating
lease liability, noncurrent |
|
— |
|
|
|
29,268 |
Deferred tax
liability |
|
10,558,687 |
|
|
|
1,363,820 |
Warrant
liability |
|
3,382,000 |
|
|
|
— |
TOTAL
LIABILITIES |
|
138,212,190 |
|
|
|
30,945,150 |
COMMITMENTS
AND CONTINGENCIES (11) |
|
|
|
SHAREHOLDERS' EQUITY (DEFICIT) |
|
|
|
Class A common stock, 0.0001 par value; 200,000,000 authorized
shares; 63,349,823 and 50,369,350 shares issued and outstanding at
September 30, 2023 and December 31, 2022,
respectively |
|
6,335 |
|
|
|
5,037 |
Additional paid-in capital |
|
194,197,780 |
|
|
|
704,963 |
Retained earnings |
|
(28,503,752 |
) |
|
|
25,487,323 |
Accumulated other comprehensive income |
|
100,175 |
|
|
|
1,052,836 |
Non-controlling interest |
|
289,248 |
|
|
|
899,538 |
Total shareholders' equity (deficit) |
|
166,089,747 |
|
|
|
28,149,697 |
TOTAL
LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) |
$ |
304,301,937 |
|
|
$ |
59,094,847 |
|
|
|
|
ABACUS LIFE, INC. Proforma
Condensed Consolidated Statement of
Operations
|
|
Three Months Ended September 30, |
|
Nine Months
Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
REVENUES: |
|
|
|
|
|
|
|
|
|
|
|
|
Portfolio servicing revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
Related party service revenue |
|
$ |
168,899 |
|
|
|
$ |
132,220 |
|
|
|
$ |
711,975 |
|
|
|
$ |
752,379 |
|
|
|
Portfolio servicing |
|
|
55,670 |
|
|
|
|
250,025 |
|
|
|
|
102,651 |
|
|
|
|
620,194 |
|
|
|
Total
Portfolio servicing revenue |
|
|
224,569 |
|
|
|
|
382,245 |
|
|
|
|
814,626 |
|
|
|
|
1,372,573 |
|
|
Active management revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Income from life insurance policies held using
investment method |
|
|
1,817,764 |
|
|
|
|
10,629,978 |
|
|
|
|
18,473,597 |
|
|
|
|
24,610,444 |
|
|
|
Change in fair value of life insurance policies (policies held
using fair value method) |
|
|
17,108,380 |
|
|
|
|
1,450,525 |
|
|
|
|
28,242,105 |
|
|
|
|
5,226,231 |
|
|
|
Total Active
management revenue |
|
|
18,926,144 |
|
|
|
|
12,080,503 |
|
|
|
|
46,715,702 |
|
|
|
|
29,836,674 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Originations revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
Related Party origination revenue |
|
|
254,517 |
|
|
|
|
3,309,628 |
|
|
|
|
3,391,814 |
|
|
|
|
12,669,023 |
|
|
|
Originations |
|
|
1,715,700 |
|
|
|
|
1,766,853 |
|
|
|
|
4,968,438 |
|
|
|
|
4,951,921 |
|
|
|
Total
Origination revenue |
|
|
1,970,217 |
|
|
|
|
5,076,481 |
|
|
|
|
8,360,252 |
|
|
|
|
17,620,944 |
|
|
|
Total Revenues |
|
21,120,930 |
|
|
|
|
17,539,229 |
|
|
|
|
55,890,580 |
|
|
|
|
48,830,191 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COST OF REVENUES (excluding depreciation and amortization stated
below) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Related party cost of revenue |
|
|
7,981 |
|
|
|
|
2,930,990 |
|
|
|
|
6,566,335 |
|
|
|
|
8,453,302 |
|
|
|
Cost of revenue |
|
|
3,356,976 |
|
|
|
|
2,687,983 |
|
|
|
|
7,554,875 |
|
|
|
|
8,039,370 |
|
|
|
Total Cost
of revenue |
|
|
3,364,957 |
|
|
|
|
5,618,973 |
|
|
|
|
14,121,210 |
|
|
|
|
16,492,673 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit |
|
|
17,755,973 |
|
|
|
|
11,920,256 |
|
|
|
|
41,769,370 |
|
|
|
|
32,337,519 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
|
1,704,154 |
|
|
|
|
14,905 |
|
|
|
|
3,116,999 |
|
|
|
|
1,664,403 |
|
|
|
General, administrative and other |
|
|
9,838,951 |
|
|
|
|
2,344,237 |
|
|
|
|
15,961,962 |
|
|
|
|
6,938,942 |
|
|
|
(Gain) loss on change in fair value of debt |
|
|
(2,088,797 |
) |
|
|
|
(1,235,032 |
) |
|
|
|
309,865 |
|
|
|
|
(859,519 |
) |
|
|
Unrealized loss (gain) on investments |
|
|
306,800 |
|
|
|
|
246,846 |
|
|
|
|
(491,356 |
) |
|
|
|
1,301,821 |
|
|
|
Depreciation and amortization expense |
|
|
1,694,853 |
|
|
|
|
4,219 |
|
|
|
|
1,702,591 |
|
|
|
|
12,360 |
|
|
|
Total
Operating expenses |
|
|
11,455,961 |
|
|
|
|
1,375,175 |
|
|
|
|
20,600,061 |
|
|
|
|
9,058,007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Income |
|
$ |
6,300,012 |
|
|
|
$ |
10,545,081 |
|
|
|
$ |
21,169,309 |
|
|
|
$ |
23,279,512 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER INCOME
(EXPENSE) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
fair value of warrant liability |
|
|
(943,400 |
) |
|
|
|
- |
|
|
|
|
(943,400 |
) |
|
|
|
- |
|
|
|
Interest
(expense) |
|
|
(2,679,237 |
) |
|
|
|
(2,449 |
) |
|
|
|
(3,632,420 |
) |
|
|
|
(1,449 |
) |
|
|
Interest
income |
|
|
63,826 |
|
|
|
|
- |
|
|
|
|
73,200 |
|
|
|
|
- |
|
|
|
Other income
(expense) |
|
|
20,086 |
|
|
|
|
42,288 |
|
|
|
|
(1,565 |
) |
|
|
|
(199,959 |
) |
|
|
Total other income (expense) |
|
|
(3,538,725 |
) |
|
|
|
39,839 |
|
|
|
|
(4,504,185 |
) |
|
|
|
(201,408 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
before provision for income taxes |
|
|
2,761,287 |
|
|
|
|
10,584,920 |
|
|
|
|
16,665,124 |
|
|
|
|
23,078,104 |
|
|
|
Income tax expense |
|
|
1,710,315 |
|
|
|
|
(948,600 |
) |
|
|
|
2,240,708 |
|
|
|
|
(650,794 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET
INCOME |
|
|
1,050,972 |
|
|
|
|
11,533,520 |
|
|
|
|
14,424,416 |
|
|
|
|
23,728,898 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LESS: NET
INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTEREST |
|
|
147,611 |
|
|
|
|
363,452 |
|
|
|
|
(339,692 |
) |
|
|
|
770,093 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME
ATTRIBUTABLE TO SHAREHOLDERS |
|
$ |
903,361 |
|
|
|
$ |
11,170,068 |
|
|
|
$ |
14,764,108 |
|
|
|
$ |
22,958,805 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EARNINGS PER
SHARE: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per
share - basic and diluted |
|
$ |
0.01 |
|
|
|
$ |
0.22 |
|
|
|
$ |
0.27 |
|
|
|
$ |
0.46 |
|
|
|
Weighted-average units outstanding—basic and diluted |
|
|
63,349,823 |
|
|
|
|
50,369,350 |
|
|
|
|
54,632,826 |
|
|
|
|
50,369,350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET
INCOME |
|
|
1,050,972 |
|
|
|
|
11,533,520 |
|
|
|
|
14,424,416 |
|
|
|
|
23,728,898 |
|
|
|
Other
comprehensive income, net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of debt |
|
|
(1,016,034 |
) |
|
|
|
2,017,559 |
|
|
|
|
(1,599,104 |
) |
|
|
|
1,494,476 |
|
|
|
Comprehensive income before non-controlling interests |
|
|
34,938 |
|
|
|
|
13,551,079 |
|
|
|
|
12,825,312 |
|
|
|
|
25,223,374 |
|
|
|
Comprehensive income (loss) attributable to non-controlling
interests |
|
|
(91,292 |
) |
|
|
|
1,011,909 |
|
|
|
|
(709,641 |
) |
|
|
|
1,136,586 |
|
|
|
Comprehensive income attributable to Abacus Life Inc. |
|
$ |
126,230 |
|
|
|
$ |
12,539,170 |
|
|
|
$ |
13,534,953 |
|
|
|
$ |
24,086,788 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* 2022 solely includes
historical results for Abacus Settlements, LLC and Longevity Market
Assets, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ABACUS LIFE, INC. Proforma Adjusted Net Income and
Adjusted EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
Proforma adjusted Net Income and Adjusted EPS |
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
Net income attributable to Abacus Life, Inc. |
|
$ |
903,361 |
|
|
|
$ |
9,992,003 |
|
|
|
$ |
15,739,009 |
|
|
|
$ |
21,507,702 |
|
|
Net income
for Abacus Settlements, LLC |
|
|
— |
|
|
|
|
(122,998 |
) |
|
|
|
(974,901 |
) |
|
|
|
149,790 |
|
|
Proforma net
income attributable to Abacus Life, Inc. |
|
|
903,361 |
|
|
|
|
9,869,005 |
|
[1] |
|
|
14,764,108 |
|
[2] |
|
|
21,657,492 |
|
[3] |
Net income
attributable to non-controlling interests |
|
|
147,611 |
|
|
|
|
363,452 |
|
|
|
|
(339,692 |
) |
|
|
|
770,093 |
|
|
Amortization
expense |
|
|
1,682,083 |
|
|
|
|
— |
|
|
|
|
1,682,083 |
|
|
|
|
— |
|
|
Stock
compensation expense |
|
|
4,583,632 |
|
|
|
|
— |
|
|
|
|
4,583,632 |
|
|
|
|
— |
|
|
Change in
fair value of warrant liability |
|
|
943,400 |
|
|
|
|
— |
|
|
|
|
943,400 |
|
|
|
|
— |
|
|
Tax impact
of items listed above |
|
|
908,271 |
|
|
|
|
|
|
|
908,271 |
|
|
|
|
|
Proforma
adjusted Net Income |
|
$ |
9,168,359 |
|
|
|
$ |
10,232,457 |
|
|
|
$ |
22,541,803 |
|
|
|
$ |
22,427,585 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares of Class A common stock outstanding |
|
|
63,349,823 |
|
|
|
|
50,369,350 |
|
|
|
|
54,632,826 |
|
|
|
|
50,369,350 |
|
|
Proforma
Adjusted EPS |
|
$ |
0.14 |
|
|
|
$ |
0.20 |
|
|
|
$ |
0.41 |
|
|
|
$ |
0.45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
Includes historical
net income attributable to Abacus Life Inc. for the three months
ended September 30, 2022 of $9,992,003 and a net loss of ($122,998)
for Abacus Settlements, LLC. |
[2] |
|
Includes year-to-date
net income attributable to Abacus Life Inc. as of September 30,
2023 of $15,739,009 plus net loss for the six month period ended on
June 30, 2023 for Abacus Settlements, LLC of ($974,901). |
|
[3] |
|
Includes historical
net income attributable to Abacus Life Inc. for the nine months
ended September 30, 2022 of $21,507,702 and $149,790 for Abacus
Settlements, LLC. |
|
|
|
ABACUS LIFE, INC. Proforma Adjusted
EBITDA
|
Proforma adjusted EBITDA |
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
Net Income
for Abacus Life Inc. |
|
|
|
|
$ |
10,355,455 |
|
|
|
$ |
15,399,317 |
|
|
|
$ |
22,277,795 |
|
|
Net Income
for Abacus Settlements, LLC |
|
|
|
|
|
(122,998 |
) |
|
|
|
(974,901 |
) |
|
|
|
149,790 |
|
|
Proforma Net
Income |
|
|
1,050,972 |
|
|
|
|
10,232,457 |
|
[1] |
|
|
14,424,416 |
|
[2] |
|
|
22,427,585 |
|
[3] |
Depreciation |
|
|
12,770 |
|
|
|
|
4,219 |
|
|
|
|
20,508 |
|
|
|
|
12,360 |
|
|
Amortization |
|
|
1,682,083 |
|
|
|
|
— |
|
|
|
|
1,682,083 |
|
|
|
|
— |
|
|
Interest
expense |
|
|
2,679,237 |
|
|
|
|
2,449 |
|
|
|
|
3,632,420 |
|
|
|
|
1,449 |
|
|
Interest
income |
|
|
(63,826 |
) |
|
|
|
— |
|
|
|
|
(73,200 |
) |
|
|
|
— |
|
|
Income tax
expense |
|
|
1,710,315 |
|
|
|
|
(948,600 |
) |
|
|
|
2,240,708 |
|
|
|
|
(650,794 |
) |
|
Stock
compensation |
|
|
4,583,632 |
|
|
|
|
— |
|
|
|
|
4,583,632 |
|
|
|
|
— |
|
|
Other
(Income) / Expenses |
|
|
(20,086 |
) |
|
|
|
(42,288 |
) |
|
|
|
1,565 |
|
|
|
|
199,959 |
|
|
Change in
fair value of warrant liability |
|
|
943,400 |
|
|
|
|
— |
|
|
|
|
943,400 |
|
|
|
|
— |
|
|
Expense
support agreement |
|
|
— |
|
|
|
|
283,047 |
|
|
|
|
— |
|
|
|
|
283,047 |
|
|
Change in
fair value of debt |
|
|
(2,088,797 |
) |
|
|
|
(1,235,032 |
) |
|
|
|
309,865 |
|
|
|
|
(859,519 |
) |
|
Unrealized
loss / (gain) on investments |
|
|
306,800 |
|
|
|
|
246,846 |
|
|
|
|
(491,356 |
) |
|
|
|
1,301,821 |
|
|
Proforma
Adjusted EBITDA |
|
$ |
10,796,500 |
|
|
|
$ |
8,543,099 |
|
|
|
$ |
27,274,041 |
|
|
|
$ |
22,715,908 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
|
$ |
21,120,930 |
|
|
|
$ |
17,539,229 |
|
|
|
$ |
55,890,580 |
|
|
|
$ |
48,830,191 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proforma
Adjusted EBITDA Margin |
|
|
51.12 |
% |
|
|
|
48.71 |
% |
|
|
|
48.80 |
% |
|
|
|
46.52 |
% |
|
Proforma Net
Income Margin |
|
|
4.98 |
% |
|
|
|
58.34 |
% |
|
|
|
25.81 |
% |
|
|
|
45.93 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
Includes historical
net income for the three months ended September 30, 2022 of
$10,355,455 for Abacus Life Inc. and a loss of ($122,998) for
Abacus Settlements, LLC. |
[2] |
|
Includes year-to-date
net income as of September 30, 2023 of $15,399,317 plus net loss
for the six month period ended on June 30, 2023 for Abacus
Settlements, LLC of ($974,901). |
|
[3] |
|
Includes historical
net income for the nine months ended September 30, 2022 of
$22,277,795 for Abacus Life Inc. and $149,790 for Abacus
Settlements, LLC. |
|
|
|
|
|
|
|
|
|
|
|
|
|
ABACUS LIFE, INC. Proforma Segment
Revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
Proforma Segment revenue |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
Portfolio Servicing |
|
$ |
224,569 |
|
|
|
$ |
382,245 |
|
|
|
$ |
814,626 |
|
|
|
$ |
1,372,573 |
|
|
Active
Management |
|
|
18,926,144 |
|
|
|
|
12,080,008 |
|
[3] |
|
|
46,715,702 |
|
[3] |
|
|
29,836,674 |
|
[3] |
Originations |
|
|
10,214,489 |
|
|
|
|
6,031,481 |
|
|
|
|
23,399,165 |
|
[1] |
|
|
19,046,144 |
|
|
Total
Revenue (including intersegment) |
|
|
29,365,202 |
|
|
|
|
18,493,734 |
|
|
|
|
70,929,493 |
|
|
|
|
50,255,391 |
|
|
Intersegment
elimination |
|
|
(8,244,272 |
) |
|
|
|
(955,000 |
) |
[2] |
|
|
(15,038,913 |
) |
|
|
|
(1,425,200 |
) |
[2] |
Total
Revenue |
|
$ |
21,120,930 |
|
|
|
$ |
17,538,734 |
|
|
|
$ |
55,890,580 |
|
|
|
$ |
48,830,191 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
Includes historical
Abacus Settlements, LLC revenue for the period ended June 30, 2023
plus the three months of revenue for the period ended September 30,
2023. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[2] |
|
Represents amount paid
from Longevity Market Assets, LLC to Abacus Settlements, LLC for
origination services, as disclosed in the related party footnote
within the Abacus Settlements, LLC financial statements. |
|
|
|
|
|
|
|
|
|
|
|
|
|
[3] |
|
Includes historical
Active Management revenue plus the intersegment activity related to
the origination services that Abacus Settlements, LLC is performing
for Longevity Market Assets. |
|
|
|
As the origination
intersegment revenue is eliminated, this would result in an
incremental change in fair value of the life settlement policies
that were originated by Abacus Settlements, LLC, as it would reduce
their cost basis. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ABACUS LIFE, INC. Return on Invested Capital
(ROIC)
|
|
|
|
|
|
|
For
the Period Ended |
|
|
|
|
|
September 30, 2023 |
|
|
Total Assets |
|
$ |
304,301,937 |
|
|
Less: |
|
|
|
Intangible assets, net |
|
|
(31,217,917 |
) |
|
Goodwill |
|
|
(140,287,000 |
) |
|
Current Liabilities |
|
|
(5,457,675 |
) |
|
Total
Invested Capital |
|
$ |
127,339,345 |
|
|
|
|
|
|
Net
Income Attributable to shareholders |
|
$ |
903,361 |
|
|
Annualized ROIC |
|
|
2.8 |
% |
|
|
|
|
|
Proforma Adjusted Net income |
|
$ |
9,168,359 |
|
|
Adjusted Annualized ROIC |
|
|
29 |
% |
|
|
|
|
|
ABACUS LIFE, INC. Return on Equity
(ROE)
|
|
|
|
|
|
|
|
|
|
|
For the Period Ended |
|
|
|
|
|
September 30, 2023 |
|
|
Total
Shareholder Equity |
|
$ |
166,089,747 |
|
|
|
|
|
|
Net
Income Attributable to shareholders |
|
$ |
903,361 |
|
|
Annualized ROE |
|
|
2.2 |
% |
|
|
|
|
|
Proforma Adjusted Net income |
|
$ |
9,168,359 |
|
|
Adjusted Annualized ROE |
|
|
22 |
% |
|
Abacus Life (NASDAQ:ABL)
過去 株価チャート
から 5 2024 まで 6 2024
Abacus Life (NASDAQ:ABL)
過去 株価チャート
から 6 2023 まで 6 2024